Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Isaacs

Showing results (451-460 of 499) with videos related to

Pageof 50
Sort By:
Cancer Research|March 1, 2005
A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer riskGoutham Narla, Analisa Difeo, Helen L Reeves, et al.
European Urology Open Science|August 2, 2021
Combined Longitudinal Clinical and Autopsy Phenomic Assessment in Lethal Metastatic Prostate Cancer: Recommendations for Advancing Precision MedicineJuho Jasu, Teemu Tolonen, Emmanuel S Antonarakis, et al.
Journal of the National Cancer Institute|December 13, 2007
Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IPDavid Duggan, Siqun L Zheng, Michele Knowlton, et al.
Journal of the National Cancer Institute|August 19, 2004
Combined genome-wide scan for prostate cancer susceptibility genesElizabeth M Gillanders, Jianfeng Xu, Bao-li Chang, et al.
The Journal of Pathology|October 18, 2023
Characterization of HOXB13 expression patterns in localized and metastatic castration-resistant prostate cancerRadhika A Patel, Erolcan Sayar, Ilsa Coleman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2015
Germline Variants in Asporin Vary by Race, Modulate the Tumor Microenvironment, and Are Differentially Associated with Metastatic Prostate CancerPaula J Hurley, Debasish Sundi, Brian Shinder, et al.
Oncogene|November 8, 2016
TET2 binds the androgen receptor and loss is associated with prostate cancerM L Nickerson, S Das, K M Im, et al.
Nature Genetics|September 2, 2008
Evidence for two independent prostate cancer risk-associated loci in the HNF1B gene at 17q12Jielin Sun, Siqun Lilly Zheng, Fredrik Wiklund, et al.
Genetic Epidemiology|June 18, 2016
Post hoc Analysis for Detecting Individual Rare Variant Risk Associations Using Probit Regression Bayesian Variable Selection Methods in Case-Control Sequencing StudiesNicholas B Larson, Shannon McDonnell, Lisa Cannon Albright, et al.
Plos Genetics|June 4, 2011
Characterizing genetic risk at known prostate cancer susceptibility loci in African AmericansChristopher A Haiman, Gary K Chen, William J Blot, et al.
Pageof 50

Showing results (451-460 of 499) with videos related to

Sort By:
Pageof 50
Cancer Research|March 1, 2005
A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer riskGoutham Narla, Analisa Difeo, Helen L Reeves, et al.
European Urology Open Science|August 2, 2021
Combined Longitudinal Clinical and Autopsy Phenomic Assessment in Lethal Metastatic Prostate Cancer: Recommendations for Advancing Precision MedicineJuho Jasu, Teemu Tolonen, Emmanuel S Antonarakis, et al.
Journal of the National Cancer Institute|December 13, 2007
Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IPDavid Duggan, Siqun L Zheng, Michele Knowlton, et al.
Journal of the National Cancer Institute|August 19, 2004
Combined genome-wide scan for prostate cancer susceptibility genesElizabeth M Gillanders, Jianfeng Xu, Bao-li Chang, et al.
The Journal of Pathology|October 18, 2023
Characterization of HOXB13 expression patterns in localized and metastatic castration-resistant prostate cancerRadhika A Patel, Erolcan Sayar, Ilsa Coleman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2015
Germline Variants in Asporin Vary by Race, Modulate the Tumor Microenvironment, and Are Differentially Associated with Metastatic Prostate CancerPaula J Hurley, Debasish Sundi, Brian Shinder, et al.
Oncogene|November 8, 2016
TET2 binds the androgen receptor and loss is associated with prostate cancerM L Nickerson, S Das, K M Im, et al.
Nature Genetics|September 2, 2008
Evidence for two independent prostate cancer risk-associated loci in the HNF1B gene at 17q12Jielin Sun, Siqun Lilly Zheng, Fredrik Wiklund, et al.
Genetic Epidemiology|June 18, 2016
Post hoc Analysis for Detecting Individual Rare Variant Risk Associations Using Probit Regression Bayesian Variable Selection Methods in Case-Control Sequencing StudiesNicholas B Larson, Shannon McDonnell, Lisa Cannon Albright, et al.
Plos Genetics|June 4, 2011
Characterizing genetic risk at known prostate cancer susceptibility loci in African AmericansChristopher A Haiman, Gary K Chen, William J Blot, et al.
Pageof 50